Egypt Neurology Devices Market Report 2022 to 2030

Egypt Neurology Devices Market Analysis

$ 3999

The Egypt Neurology Device Market is expected to witness growth from $35 Mn in 2022 to $72 Mn in 2030 with a CAGR of 9.30% for the forecasted year 2022-2030. There is a rising need for neurology devices in Egypt due to the frequency of neurological disorders such as stroke, epilepsy, Parkinson's disease, and multiple sclerosis. The market is segmented by product type and by the end user. Major Key players in Malaysia's neurology devices market include Wassenburg Medical, EMG-EP Technologies, Johnson and Johnson, GE Healthcare, Stryker, Medtronic and Abbott laboratories.

ID: IN10EGMD012 CATEGORY: Medical Devices GEOGRAPHY: Egypt AUTHOR: Jigyasu Bhandari

Buy Now

Egypt Neurology Devices Market Executive Analysis

The Egypt Neurology Devices Market size is at around $35 Mn in 2022 and is projected to reach $72 Mn in 2030, exhibiting a CAGR of 9.30% during the forecast period. Till 2021, the health sector in Egypt received just an average allocation of 5.2% of the total government budget or 1.5% of GDP. From 5.3% in 2016 to 4.9% in 2019, the budget's share of health expenses decreased, reaching its lowest level in the preceding five years. At 1.6% of GDP, government spending on health reached a record high. Egypt has boosted public health spending to approximately 3% of GDP.

In Egypt, there are 76 strokes per 100,000 people each year and 5.5 epilepsy cases per 1,000 people. There are 41.2 cases of Parkinson's disease for every 100,000 people and 3.5 cases of Multiple Sclerosis (MS) for every 100,000 people. Neurology examines diseases that have an impact on the nervous system. In neurology, a variety of various kinds of devices are routinely employed. For instance, sacral nerve stimulation devices electrically stimulate the targeted sacral nerves in the lower back. Contrarily, equipment for managing cerebrospinal fluid maintains the fluid's consistent flow and drains surplus fluid from the brain. As a result, while interventional devices use radiology and catheters to diagnose the medical conditions present in the central nervous system, Deep Brain Stimulation (DBS) devices assist in performing procedures by implanting a medical device that sends electrical impulses to specific target areas in the brain.

Egypt Neurology Device Market Analysis

Market Dynamics

Market Growth Drivers

There is a rising need for neurology devices in Egypt due to the frequency of neurological disorders such as stroke, epilepsy, Parkinson's disease, and multiple sclerosis. These problems can be diagnosed and treated with neurology devices. The Egyptian government is taking steps to assist the expansion of the healthcare industry, including providing financial incentives for companies that make neurology devices to invest there. This is anticipated to spur the entry of more manufacturers and fuel the market's expansion for neurology devices.

Market Restraints

The complexity and length of the Egyptian neurology device regulations may hinder manufacturers' efforts to launch new items into the market swiftly. Due to their high price, restricted availability, or lack of adequate training and knowledge to use them, innovative neurological devices and technologies may not be widely available to many healthcare providers in Egypt.

Competitive Landscape

Key Players

Wassenburg Medical (EG)
EMG-EP Technologies (EG)
Medtronic
Abbott Laboratories
Johnson & Johnson
Boston Scientific
GE Healthcare

Recent Notable Deals

2021: Leading medical device manufacturer Medtronic announced the arrival of its Percept PC neurostimulator in Egypt in 2021. The tool is utilized to treat Parkinson's disease and essential tremor symptoms.

2020: Many Egyptian neurology centres will start receiving neurology devices from Mindray, a Chinese manufacturer of neurology devices, in 2020. Providing electroencephalography equipment, which is used to track brain activity, was part of the agreement.

Healthcare Policies and Regulatory Landscape

The Egyptian Ministry of Health and Population (MoHP) and the Egyptian Drug Administration (EDA) oversee healthcare laws and regulations in Egypt's neurology devices sector. In Egypt, the registration of neurological devices is governed by the EDA. Manufacturers must abide by the EDA's rules for registering neurological devices, which include providing clinical and technical data for approval. Manufacturers of neurology devices are required by the Egyptian Drug Administration (EDA) to implement a Quality Management System (QMS) in line with ISO 13485. The entire device lifespan, from design and development to post-market monitoring and complaint management, must be covered by the QMS.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Neurology Device Market Segmentation

The Neurology Device Market is segmented as mentioned below:

By Product Type (Revenue, USD Billion):

Neurostimulation
?Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation
Vagus Nerve Stimulation
Gastric Electric Stimulation
Interventional Neurology
- Aneurysm Coiling & Embolization
- Embolic Coils
- Flow Diversion Devices
- Liquid Embolic Agents
- Cerebral Balloon Angioplasty & Stenting
- Carotid Artery Stents
- Filter Devices
- Balloon Occlusion Devices
- Neurothrombectomy
- Clot Retriever
- Suction Aspiration Devices
- Snares
CSF Management
- CSF Shunts
- CSF Drainage
Neurosurgery Devices
- Ultrasonic Aspirators
- Stereotactic Systems
- Neuroendoscopes
- Aneurysm Clips

By End User (Revenue, USD Billion):

??Hospitals and Clinics
Specialty Centres
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.